8-KItem 7.01 · Reg FD Disclosure
Labcorp Reaffirms Long-Term Outlook Despite Proposed Medicare Rate Cuts
Filed with the SEC on · Summarized by InvestorsBot
Labcorp said CMS released preliminary Clinical Laboratory Fee Schedule rates for 2027-2029 on September 21, 2026, and warned that the rates could impose steep annual payment cuts and threaten access to laboratory services. The company reaffirmed its 2026-2029 outlook of 5%-8% annual revenue growth, 75-150 basis points of adjusted operating-margin expansion by 2029, 8.5%-11.5% annual adjusted EPS growth, and free-cash-flow growth in line with adjusted earnings; it expects to address the rates’ effect on 2027 guidance in February 2027.